Canadian energy producer and Bitcoin miner New West Data is exploring a US initial public offering to help meet the growing need for powerful computing systems. The Calgary-based firm operates oil ...

At the 2026 Mobile World Congress in Barcelona, Deutsche Telekom showcased a comprehensive vision that moves far beyond its traditional telecommunications roots. The company’s presentations ...

U.S. President Donald Trump announced Nvidia will be able to sell a more advanced H200 chip to China. Several analysts were quick to point out this move would help boost China's AI capabilities.

Duke Energy has reaffirmed its role in a US Department of Energy cost-share project backing GE Vernova Hitachi’s BWRX-300 small modular reactor technology and is preparing an early site permit ...

Odys Aviation plans to go to market with the Laila, a subscale, uncrewed version of its planned nine-passenger regional aircraft. Credit: Odys Aviation The advanced air mobility industry has endured a ...

Abstract: All AESS Chapters and IEEE Sections are encouraged to take advantage of the AESS Distinguished Lecturer and Tutorial Program for their regular or special meetings. We have selected an ...

Once traditional staples of television, tutorial-based cooking shows are disappearing from the TV screen. The Food Network, alongside its spinoff, Cooking Channel, has long dominated the food category ...

bDepartment of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands cDepartment of Medical Oncology, Amsterdam UMC, VU ...

Michael is an editor at Game Rant and a journalist with several years of experience writing about video games, television, and social issues. He loves indie platformers, Pokémon, and Hack 'n Slashers.

The news about Samsung snapping an advanced packaging order for Nvidia’s AI chips paired with high-bandwidth memory (HBM) chips underscores the strategic importance of next-generation packaging ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR) today announced a strategic pivot aimed at advancing its clinical-stage candidate stenoparib, a novel PARP/Tankyrase dual ...